The primary goal of treatment for vestibular schwannoma is to achieve local control without comprimising regional cranial nerve function. Stereotactic radiosurgery has emerged as a viable therapeutic option for vestibular schwannoma. The aim of the study is to report our 15-year single center experience using linear accelerator-based stereotactic radiosurgery in the management of patients with vestibular schwannoma.
Methods and study design
Between July 1998 and January 2013, 68 patients with unilateral vestibular schwannoma were treated using stereotactic radiosurgery at the Department of Radiation Oncology, Gulhane Military Medical Academy. All patients underwent high-precision stereotactic radiosurgery using a linear accelerator with 6-MV photons.
Results
Median follow-up time was 51 months (range, 9–107). Median age was 45 years (range, 20–77). Median dose was 12 Gy (range, 10–13) prescribed to the 85%-95% isodose line encompassing the target volume. Local tumor control in patients with periodic follow-up imaging was 96.1%. Overall hearing preservation rate was 76.5%.
Conclusions
Linear accelerator-based stereotactic radiosurgery offers a safe and effective treatment for patients with vestibular schwannoma by providing high local control rates along with improved quality of life through well-preserved hearing function.
EvansD.G., MoranA., KingA., SaeedS., GurusingheN., RamsdenR.: Incidence of vestibular Schwannoma and neurofibromatosis 2 in the North West of England over a 10-year period: higher incidence than previously thought. Otol Neurotol, 26: 93–97, 2005.
3.
HoaM., DrazinD., HannaG., SchwartzM.S., LekovicG.P.: The approach to the patient with incidentally diagnosed vestibular Schwannoma. Neurosurg Focus, 33: E2, 2012.
4.
GardnerG., RobertsonJ.H.: Hearing preservation in unilateral acoustic neuroma surgery. Ann Otol Rhinol Laryngol, 97: 55–66, 1988.
SakamotoT., FukudaS., InuyamaY.: Hearing loss and growth rate of acoustic neuromas in follow-up observation policy. Auris Nasus Larynx, 28 Suppl: S23–27, 2001.
7.
MulderJ.J., KaandersJ.H., van OverbeekeJ.J., CremersC.W.: Radiation therapy for vestibular Schwannomas. Curr Opin Otolaryngol Head Neck Surg, 20: 367–371, 2012.
8.
ArthursB.J., FairbanksR.K., DemakasJ.J., LamoreauxW.T., GiddingsN.A., MackayA.R., CookeB.S., ElaimyA.L., LeeC.M.: A review of treatment modalities for vestibular Schwannoma. Neurosurg Rev, 34: 265–279, 2011.
9.
ArltF., TrantakisC., KruppW., RennerC., WinklerD., StraussG., MeixensbergerJ.: Cerebrospinal fluid leak after microsurgical surgery in vestibular Schwannomas via retrosigmoidal craniotomy. Neurol Res, 33: 947–952, 2011.
10.
AnsariS.F., TerryC., Cohen-GadolA.A.Surgery for vestibular Schwannomas: a systematic review of complications by approach. Neurosurg Focus, 33: E14, 2012.
11.
KondziolkaD., MousaviS.H., KanoH., FlickingerJ.C., LunsfordL.D.: The newly diagnosed vestibular Schwannoma: radiosurgery, resection, or observation?Neurosurg Focus, 33: E8, 2012.
12.
MilliganB.D., PollockB.E., FooteR.L., LinkM.J.: Long-term tumor control and cranial nerve outcomes following γ-knife surgery for larger-volume vestibular Schwannomas. J Neurosurg, 116: 598–604, 2012.
13.
SunS., LiuA.: Long-term follow-up studies of gamma knife surgery with a low margin dose for vestibular Schwannoma. J Neurosurg, 117: 57–62, 2012.
FooteK.D., FriedmanW.A., BuattiJ.M., MeeksS.L., BovaF.J., KubilisP.S.: Analysis of risk factors associated with radiosurgery for vestibular Schwannoma. J Neurosurg, 95: 440–449, 2001.
16.
SpiegelmannR., LidarZ., GofmanJ., AlezraD., HadaniM., PfefferR.: Linear accelerator radiosurgery for vestibular schwannoma. J Neurosurg, 94: 7–13, 2001.
17.
RoosD.E., PotterA.E., BrophyB.P.: Stereotactic radiosurgery for acoustic neuromas: what happens long term?Int J Radiat Oncol Biol Phys, 82: 1352–1355, 2012.
18.
van de LangenbergR., DohmenA.J., de BondtB.J., NelemansP.J., BaumertB.G., StokroosR.J.: Volume changes after stereotactic LINAC radiotherapy in vestibular Schwannoma: control rate and growth patterns. Int J Radiat Oncol Biol Phys, 84: 343–349, 2012.
19.
FriedmanW.A., BradshawP., MyersA., BovaF.J.: Linear accelerator radiosurgery for vestibular Schwannomas. J Neurosurg, 105: 657–661, 2006.
20.
PollockB.E., DriscollC.L., FooteR.L., LinkM.J., GormanD.A., BauchC.D., MandrekarJ.N., KreckeK.N., JohnsonC.H.: Patient outcomes after vestibular Schwannoma management: a prospective comparison of microsurgical resection and stereotactic radiosurgery. Neurosurgery, 59: 77–85, 2006.
21.
MurphyE.S., SuhJ.H.: Radiotherapy for vestibular Schwannomas: a critical review. Int J Radiat Oncol Biol Phys, 79: 985–997, 2011.
22.
ChopraR., KondziolkaD., NiranjanA., LunsfordL.D., FlickingerJ.C.: Long-term follow-up of acoustic Schwannoma radiosurgery with marginal tumor doses of 12 to 13 Gy. Int J Radiat Oncol Biol Phys, 68: 845–851, 2007.
23.
SirinS., OysulK., SurenkokS., SagerO., DincoglanF., DiricanB., BeyzadeogluM.: Linear accelerator-based stereotactic radiosurgery in recurrent glioblastoma: a single center experience. Vojnosanit Pregl, 68: 961–966, 2011.
24.
SurenkokS., SagerO., DincoglanF., GamsizH., DemiralS., UysalB., SirinS., OysulK., BeyzadeogluM.: Stereotactic radiosurgery in pituitary adenomas: a single center experience. Int J Hematol Oncol, 22: 255–260, 2012.
25.
DincoglanF., SagerO., GamsizH., DemiralS., UysalB., SurenkokS., SirinS., OysulK., BeyzadeogluM.: Management of arteriovenous malformations by stereotactic radiosurgery: a single center experience. Int J Hematol Oncol, 22: 107–112, 2012.
26.
DincoglanF., SagerO., GamsizH., UysalB., DemiralS., DiricanB., OysulK., SurenkokS., SirinS., BeyzadeogluM.: Stereotactic radiosurgery for intracranial tumors: a single center experience. Gulhane Med J, 54: 190–198, 2012.
27.
AoyamaH., OnoderaS., TakeichiN., OnimaruR., TerasakaS., SawamuraY., ShiratoH.: Symptomatic outcomes in relation to tumor expansion after fractionated stereotactic radiation therapy for vestibular Schwannomas single-institutional long-term experience. Int J Radiat Oncol Biol Phys, 85: 329–334, 2013.
28.
HayhurstC., ZadehG.: Tumor pseudoprogression following radiosurgery for vestibular Schwannoma. Neuro Oncol, 14: 87–92, 2012.
29.
MeijerO.W., WeijmansE.J., KnolD.L., SlotmanB.J., BarkhofF., VandertopW.P., CastelijnsJ.A.: Tumor-volume changes after radiosurgery for vestibular Schwannoma: implications for follow-up MR imaging protocol. Am J Neuroradiol, 29: 906–910, 2008.
30.
OkunagaT., MatsuoT., HayashiN., HayashiY., ShabaniH.K., KaminogoM., OchiM., NagataI.: Linear accelerator radiosurgery for vestibular Schwannoma: measuring tumor volume changes on serial three-dimensional spoiled gradient-echo magnetic resonance images. J Neurosurg, 103: 53–58, 2005.
31.
PollockB.E., LunsfordL.D., KondziolkaD., SekulaR., SubachB.R., FooteR.L., FlickingerJ.C.: Vestibular Schwannoma management. Part II. Failed radiosurgery and the role of delayed microsurgery. J Neurosurg, 89: 949–955, 1998.
32.
FriedmanR.A., BerlinerK.I., BassimM., UrsickJ., SlatteryWH3rd, SchwartzM.S., BrackmannD.E.: A paradigm shift in salvage surgery for radiated vestibular Schwannoma. Otol Neurotol, 32: 1322–1328, 2011.
33.
FongB.M., PezeshkianP., NagasawaD.T., De SallesA., GopenQ., YangI.: Hearing preservation after LINAC radiosurgery and LINAC radiotherapy for vestibular Schwannoma. J Clin Neurosci, 19: 1065–1070, 2012.
34.
CollenC., AmpeB., GevaertT., MoensM., LinthoutN., De RidderM., VerellenD., D'HaensJ., StormeG.: Single fraction versus fractionated linac-based stereotactic radiotherapy for vestibular Schwannoma: a single-institution experience. Int J Radiat Oncol Biol Phys, 81: 503–509, 2011.
35.
KoppC., FauserC., MüllerA., AstnerS.T., JacobV., LumentaC., MeyerB., TonnJ.C., MollsM., GrosuA.L.: Stereotactic fractionated radiotherapy and LINAC radiosurgery in the treatment of vestibular Schwannoma-report about both stereotactic methods from a single institution. Int J Radiat Oncol Biol Phys, 80: 1485–1491, 2011.
